Biotech Startups

Nopalm Ingredients uses biomass fermentation with a non-GMO yeast strain to upcycle agri-food side streams (such as potato peels and rejected vegetables) into oils and fats that serve as palm oil alternatives. Its REVÓLEO platform supplies semi-solid fats for food applications and soft butters for cosmetics and personal care manufacturers.

2 investors

Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.

2 investors

Nourish Ingredients develops animal-free fats and lipids using precision fermentation, including Tastilux (a fungal-fermentation phospholipid for meaty flavour) and Creamilux (a short-chain lipid emulsifier for dairy mouthfeel). It supplies these high-potency fat ingredients to food manufacturers and brands making alternative meat and plant-based or hybrid dairy products.

2 investors

NovaFlow is an AI-powered data analysis platform that automates bioinformatics workflows for life science researchers and biotech labs, transforming raw experimental data into publication-ready results in minutes using large language models and validated computational pipelines.

2 investors

NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.

2 investors

Novira Therapeutics was a Doylestown, PA-based clinical-stage biopharmaceutical company developing small-molecule antiviral drugs, including capsid inhibitors, to cure chronic hepatitis B infection.

2 investors

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.

2 investors

Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.

2 investors

Novoron develops lipoprotein-receptor small molecule therapies aimed at repairing damage and degeneration of the brain and spinal cord, including treatments for proteinopathies and neuroregeneration following traumatic injury. The company focuses on drug discovery for neurological conditions such as neurodegeneration and cognitive decline.

2 investors

NSG Bio operates BSL-2 certified co-working wet-laboratory and office spaces for life sciences and biotech companies in Singapore, offering turnkey facilities, shared equipment, and support services for startups and multinationals conducting R&D. It also runs a sponsorship and grant program for early-stage biotech ventures, with locations at Biopolis and the Geneo Life Sciences Cluster at Singapore Science Park.

2 investors

NTx Bio develops proprietary cell-free synthetic biology platforms for on-demand, decentralized biomanufacturing of mRNA and proteins. The company serves drug developers and researchers seeking faster, scalable production of therapeutic molecules from concept to commercial manufacturing.

2 investors

Nuanced Health develops healthcare solutions, though the specific product focus is not detailed on this team page.

2 investors

A specialty pharmaceutical company focused on developing and commercializing novel therapeutics for central nervous system conditions, serving patients and healthcare providers.

2 investors

Nunatak develops microbial solutions to improve soil-plant health and help crops thrive under stress conditions, informed by plant-microbiome relationships from extreme environments. The company serves agriculture and land restoration through biological products designed to regenerate soils.

2 investors

Nuntius develops programmable nanocarriers for drug delivery that can target tissues beyond the liver and utilize machine learning to optimize carrier performance. The company serves pharmaceutical and biotech organizations developing targeted therapeutics.

2 investors

Nurami Medical develops surgical sealants and grafts using electrospun nanofiber scaffolds made from resorbable polymers to support tissue engineering and regeneration. The company creates customized biomimetic scaffolds that mimic natural tissue structure for surgical and wound healing applications.

2 investors

Nurotron develops implantable neurostimulation and neuromodulation medical devices for treating sensory and neurological disorders, including cochlear implants for hearing restoration, retinal implants for vision restoration, sacral neuromodulation for bladder dysfunction, and deep brain stimulation for movement disorders.

2 investors

Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.

2 investors

NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension. Its lead drug candidate TRIPLN combines L-leucine, metformin, and sildenafil, and it also markets LEUSIX, a dietary supplement for cardiometabolic health and weight management.

2 investors

2 investors

NuvOx Pharma is a clinical-stage pharmaceutical company developing NanO₂, an oxygen therapeutic drug intended to improve oxygen delivery from lungs to blood and to tissue in order to reverse tissue hypoxia. Its clinical programs target indications including glioblastoma (as a radiosensitizer), stroke, and respiratory distress.

2 investors

nVision Quantum develops POLARIS, an on-site system that uses parahydrogen-induced hyperpolarization to amplify metabolic imaging agents for real-time, non-invasive metabolic imaging with standard MRI. It targets research labs and clinical imaging workflows in the medical imaging field, offering automated dose production with ready-to-use kits.

2 investors

LUX BIO develops bioluminescent alternatives to replace chemiluminescent products, targeting the elimination of single-use plastic glow sticks and toxic chemicals from consumer and industrial applications. The company applies biotech solutions to address environmental sustainability challenges.

2 investors

2 investors